Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Anticoagulation for mechanical heart valves: a role for patient based therapy.

Emery RW, Emery AM, Raikar GV, Shake JG.

J Thromb Thrombolysis. 2008 Feb;25(1):18-25. Epub 2007 Dec 4. Review.

PMID:
18060537
2.

Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy.

Van Nooten GJ, Caes F, François K, Van Bellleghem Y, Bové T, Vandenplas G, Taeymans Y.

J Heart Valve Dis. 2012 Jan;21(1):88-98.

PMID:
22474748
3.

Aniticoagulation in patients following prosthetic heart valve replacement.

Akhtar RP, Abid AR, Zafar H, Khan JS.

Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):10-7.

PMID:
19262444
4.

Early postoperative anticoagulation after mechanical valve replacement: a systematic review.

Kulik A, Rubens FD, Wells PS, Kearon C, Mesana TG, van Berkom J, Lam BK.

Ann Thorac Surg. 2006 Feb;81(2):770-81. Review.

PMID:
16427905
5.

High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, et al.

J Am Coll Cardiol. 1995 Apr;25(5):1111-9.

6.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH.

J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19.

7.

Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.

Bian C, Qi X, Li L, Zhao J, Liu X.

Arch Gynecol Obstet. 2016 Jan;293(1):69-74. doi: 10.1007/s00404-015-3768-0. Epub 2015 Jun 6.

PMID:
26048261
8.

Thrombotic and bleeding complications of prosthetic heart valves.

Edmunds LH Jr.

Ann Thorac Surg. 1987 Oct;44(4):430-45. Review.

PMID:
3310938
9.

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study.

Chan V, Jamieson WR, Lam BK, Ruel M, Ling H, Fradet G, Mesana TG.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1053-8.e2. doi: 10.1016/j.jtcvs.2009.10.068. Epub 2010 May 23.

10.

[Anticoagulation of valvular prostheses].

Hanania G, Maroni JP, el Hajj Y.

Ann Cardiol Angeiol (Paris). 2003 Nov;52(5):290-6. Review. French.

PMID:
14714342
11.

The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties.

Iung B, Rodés-Cabau J.

Eur Heart J. 2014 Nov 7;35(42):2942-9. doi: 10.1093/eurheartj/ehu365. Epub 2014 Sep 8. Review.

PMID:
25205532
12.

Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.

Trujillo JF, Hollenberg SM.

FP Essent. 2017 Jun;457:23-29. Review.

PMID:
28671806
13.

Mitral valve repair and bioprosthetic replacement without postoperative anticoagulation does not increase the risk of stroke or mortality.

Schwann TA, Engoren M, Bonnell M, Clancy C, Khouri S, Kabour A, Jamil T, Habib RH.

Eur J Cardiothorac Surg. 2013 Jul;44(1):24-31. doi: 10.1093/ejcts/ezs626. Epub 2013 Jan 4.

PMID:
23293318
14.

A comparison of mechanical valve performance in a poorly anticoagulated community.

Williams MA, Crause L, Van Riet S.

J Card Surg. 2004 Sep-Oct;19(5):410-4.

PMID:
15383051
15.

Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.

Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, Fermin L, McGrath M, Kong B, Hughes C, Sethi G, Wait M, Martin T, Graeve A; PROACT Investigators.

J Thorac Cardiovasc Surg. 2014 Apr;147(4):1202-1210; discussion 1210-1. doi: 10.1016/j.jtcvs.2014.01.004. Epub 2014 Jan 12.

16.

How to define valvular atrial fibrillation?

Fauchier L, Philippart R, Clementy N, Bourguignon T, Angoulvant D, Ivanes F, Babuty D, Bernard A.

Arch Cardiovasc Dis. 2015 Oct;108(10):530-9. doi: 10.1016/j.acvd.2015.06.002. Epub 2015 Jul 14. Review.

17.

Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves.

Chesebro JH, Adams PC, Fuster V.

J Am Coll Cardiol. 1986 Dec;8(6 Suppl B):41B-56B. Review.

18.

Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.

Rafiq S, Steinbrüchel DA, Lilleør NB, Møller CH, Lund JT, Thiis JJ, Køber L, Olsen PS.

Thromb Res. 2017 Feb;150:104-110. doi: 10.1016/j.thromres.2016.11.021. Epub 2016 Nov 25.

PMID:
27914653
19.

Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.

Yamak B, Iscan Z, Mavitas B, Ulus AT, Katircioglu SF, Tasdemir O, Bayazit K.

J Heart Valve Dis. 1999 Nov;8(6):665-73.

PMID:
10616246
20.

[The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].

Wołkanin-Bartnik J, Zieliński T, Pogorzelska H, Browarek A, Leszek P, Korewicki J.

Pol Merkur Lekarski. 2005 May;18(107):503-10. Polish.

PMID:
16161943

Supplemental Content

Support Center